Innospec Inc (IOSP)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 33,200 145,100 150,100 147,300 139,000 127,000 126,400 129,600 133,000 131,300 116,000 106,000 92,800 91,700 81,000 19,000 28,700 37,200 54,600 116,500
Total stockholders’ equity US$ in thousands 1,211,200 1,243,400 1,192,600 1,183,600 1,147,100 1,125,400 1,092,200 1,078,200 1,038,000 1,089,400 1,067,900 1,068,200 1,032,400 992,500 973,600 958,600 944,400 -64,300 899,200 943,800
ROE 2.74% 11.67% 12.59% 12.45% 12.12% 11.28% 11.57% 12.02% 12.81% 12.05% 10.86% 9.92% 8.99% 9.24% 8.32% 1.98% 3.04% — 6.07% 12.34%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $33,200K ÷ $1,211,200K
= 2.74%

Innospec Inc's return on equity (ROE) has shown fluctuations over the period indicated. The trend began at 12.34% as of March 31, 2020, and experienced a slight drop to 6.07% by June 30, 2020. The ROE was not available for September 30, 2020. Thereafter, the ROE continued to decline to 3.04% by December 31, 2020, and further decreased to 1.98% by March 31, 2021.

However, the ROE saw improvements in the following quarters, with an increasing trend from 8.32% as of June 30, 2021, reaching 12.81% by December 31, 2022. The ROE fluctuated around this level, with slight variations, until September 30, 2024, where it slightly dropped to 11.67%. The ROE then experienced a significant decline to 2.74% as of December 31, 2024.

In summary, Innospec Inc's ROE has seen fluctuations over the period under review, with notable ups and downs. It is essential for stakeholders to further investigate the factors behind these fluctuations to gain a better understanding of the company's profitability and efficiency in generating returns for its shareholders.